Figure 1.
Metabolic disease states associated with increased circulating SAA. Obesity, cardiovascular disease (CVD), autoimmune diseases (including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)), diabetes (Type 1, Type 2, and gestational), inflammatory bowel disease (IBD, including Crohn's disease (CD) and ulcerative colitis (UC)), and non-alcoholic fatty liver disease (NAFLD) are chronic metabolic conditions that are all associated with increased circulating SAA levels.